Amylyx Pharmaceuticals (AMLX) News Today

→ Can't believe it's happening again (From Manward Press) (Ad)

$2.00

-0.07 (-3.38%)

(As of 02:11 PM ET)

Source

Source	Headline
	Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives Average Rating of "Hold" from Brokerages americanbankingnews.com - April 15 at 2:18 AM
	Amylyx Pharmaceuticals: A Hold Rating Amidst Promising but Preliminary HELIOS Trial Results markets.businessinsider.com - April 12 at 9:19 AM
	Hold Rating on Amylyx Pharmaceuticals Amid Uncertainties in Drug Efficacy and Market Prospects markets.businessinsider.com - April 11 at 2:34 PM
	Robert W. Baird Lowers Amylyx Pharmaceuticals (NASDAQ:AMLX) Price Target to $3.00 marketbeat.com - April 11 at 8:26 AM
	Amylyx Pharmaceuticals' Investigational Drug Shows Improved Pancreatic Function In Patients With Inherited Disorder msn.com - April 10 at 2:22 PM
	Amylyx Pharmaceuticals Announces Interim Data From Ongoing Phase 2 HELIOS Clinical Trial Demonstrating Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Syndrome finance.yahoo.com - April 10 at 9:22 AM
	Amylyx Pharmaceuticals Announces Interim Data From Ongoing Phase 2 HELIOS Clinical Trial Demonstrating Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Syndrome businesswire.com - April 10 at 9:00 AM
	The Gross Law Firm Notifies Amylyx Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - AMLX prnewswire.com - April 9 at 5:45 AM
	Amylyx Pharmaceuticals' (AMLX) "Buy" Rating Reaffirmed at HC Wainwright americanbankingnews.com - April 9 at 3:42 AM
	Amylyx Pharmaceuticals (AMLX) to Release Quarterly Earnings on Wednesday americanbankingnews.com - April 9 at 1:34 AM
	Optimistic Outlook for Amylyx Pharmaceuticals Inc with AMX0035’s Potential in Rare Diseases markets.businessinsider.com - April 8 at 1:39 PM
	48 HOUR DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Amylyx stockhouse.com - April 8 at 1:39 PM
	The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amylyx Pharmaceuticals, Inc. (AMLX) businesswire.com - April 8 at 12:00 PM
	Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Interim Data from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on April 10, 2024 businesswire.com - April 8 at 9:00 AM
	Amylyx Pharmaceuticals Shifts Focus: Hold Recommendation Amidst R&D Pivot and Revenue Impact markets.businessinsider.com - April 8 at 8:39 AM
	Unveiling 6 Analyst Insights On Amylyx Pharma markets.businessinsider.com - April 8 at 8:39 AM
	HC Wainwright Reiterates Buy Rating for Amylyx Pharmaceuticals (NASDAQ:AMLX) marketbeat.com - April 8 at 8:29 AM
	Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Amylyx Pharmaceuticals, Inc.(AMLX) Shareholders prnewswire.com - April 8 at 5:45 AM
	Analysts Just Slashed Their Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) EPS Numbers finance.yahoo.com - April 6 at 2:33 PM
	Amylyx Pharmaceuticals (AMLX) Tanks 80% After RELYVRIO ALS Treatment Fails Phase 3, Follows Securities Class Action Complaint - Hagens Berman markets.businessinsider.com - April 5 at 4:19 PM
	AMLX Investors Have Opportunity to Lead Amylyx Pharmaceuticals, Inc. Securities Fraud Lawsuit prnewswire.com - April 5 at 1:30 PM
	Amylyx Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - AMLX prnewswire.com - April 5 at 5:45 AM
	Amylyx Pharmaceuticals: Hold Rating Maintained Amidst Drug Discontinuation and Pipeline Developments markets.businessinsider.com - April 4 at 8:37 PM
	AMLX FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 9 Deadline in Securities Class Action - AMLX prnewswire.com - April 4 at 5:54 PM
	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Amylyx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - AMLX prnewswire.com - April 4 at 2:40 PM
	5-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Amylyx Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm stockhouse.com - April 4 at 10:36 AM
	Amylyx withdraws ALS drug after trial fail, slashes headcount bizjournals.com - April 4 at 10:36 AM
	Amylyx to Pull ALS Drug From Market After Failed Trial bloomberg.com - April 4 at 10:36 AM
	UPDATE 1-Amylyx Pharma to remove ALS drug from US, Canada markets finance.yahoo.com - April 4 at 10:36 AM
	ALS drug will be pulled from US market after study showed patients didn't benefit finance.yahoo.com - April 4 at 10:36 AM
	SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Amylyx prnewswire.com - April 4 at 10:15 AM
	Amylyx Is Cutting 70% of Its Workforce and Pulling ALS Drug From the Market barrons.com - April 4 at 7:43 AM
	Amylyx Pharmaceuticals to remove ALS drug from US, Canada markets reuters.com - April 4 at 7:12 AM
	Amylyx Pharmaceuticals Announces Formal Intention to Remove RELYVRIO®/ALBRIOZA™ from the Market; Provides Updates on Access to Therapy, Pipeline, Corporate Restructuring, and Strategy businesswire.com - April 4 at 7:00 AM
	Shareholders of Amylyx Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before April 9, 2024 to Discuss Your Rights - AMLX prnewswire.com - April 3 at 5:45 AM
	The Gross Law Firm Reminds Amylyx Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 9, 2024 - AMLX prnewswire.com - April 2 at 5:45 AM
	DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Amylyx markets.businessinsider.com - April 1 at 10:22 PM
	Levi & Korsinsky Reminds Amylyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 9, 2024 - AMLX prnewswire.com - April 1 at 5:45 AM
	Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Sees Significant Growth in Short Interest marketbeat.com - March 31 at 1:21 PM
	Amylyx Pharmaceuticals (AMLX) Tanks 80% After RELYVRIO(R) ALS Treatment Fails Phase 3, Follows Securities Class Action Complaint - Hagens Berman stockhouse.com - March 31 at 12:46 PM
	AMYLYX PHARMACEUTICALS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Amylyx Pharmaceuticals, Inc. - AMLX prnewswire.com - March 29 at 10:45 PM
	SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Amylyx prnewswire.com - March 29 at 10:40 AM
	The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Amylyx Pharmaceuticals, Inc.(AMLX) Shareholders prnewswire.com - March 29 at 5:45 AM
	Amylyx Pharmaceuticals: Hold Rating Maintained Amidst Development Shifts and Trial Setbacks markets.businessinsider.com - March 28 at 2:09 AM
	ROSEN, A LEADING LAW FIRM, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important April 9 Deadline in Securities Class Action - AMLX prnewswire.com - March 27 at 6:31 PM
	April 9, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against AMLX prnewswire.com - March 27 at 5:45 AM
	AMLX Investors Have Opportunity to Lead Amylyx Pharmaceuticals, Inc. Securities Fraud Lawsuit prnewswire.com - March 26 at 11:00 AM
	Shareholders of Amylyx Pharmaceuticals, Inc. Should Contact The Gross Law Firm Before April 9, 2024 to Discuss Your Rights - AMLX prnewswire.com - March 26 at 5:45 AM
	INVESTOR ALERT: AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX) INVESTORS WITH LOSSES OF MORE THAN $100,000 ENCOURAGED TO SEEK APPOINTMENT AS LEAD PLAINTIFF - April 9, 2024 DEADLINE prnewswire.com - March 25 at 8:00 AM
	INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Amylyx stockhouse.com - March 23 at 10:39 AM

Get Amylyx Pharmaceuticals News Delivered to You Automatically

Can't believe it's happening again (Ad)

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.

AMLX Media Mentions By Week

AMLX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AMLX
News Sentiment
▼
0.34

0.66
▲
Average
Medical
News Sentiment

AMLX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AMLX Articles
This Week
▼
8

6
▲
AMLX Articles
Average Week

Get Amylyx Pharmaceuticals News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:AMLX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Amylyx Pharmaceuticals (AMLX) News Today

AMLX Media Mentions By Week

AMLX Media Sentiment

AMLX News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info